Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. ACN
3. IBM
4. MU
5. PRIM
6. META
7. SPY
8. DPZ
9. NAVN
10. NVDA

Go back to Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Reports In-Line Q4 EPS

February 17, 2021 4:26 PM EST

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.15), in-line with the analyst estimate of ($0.15).

"2020 was a strong and productive year for Viking," stated Brian Lian, Ph.D., chief executive officer of Viking. "Despite the challenges posed by the global pandemic, we continued to open clinical sites and proceed with... More